Hemolyzed samples may indicate
mistreatment of a specimen before receipt
by the laboratory; hence the results should
be interpreted with caution.
Centrifuging serum samples before a
complete clot forms may result in the
presence of fibrin. To prevent erroneous
results due to the presence of fibrin,
ensure that complete clot formation has
taken place prior to centrifugation of
samples. Some samples, particularly
those from patients receiving
anticoagulant therapy, may require
increased clotting time.
Blood collection tubes from different
manufacturers may yield differing values,
depending on materials and additives,
including gel or physical barriers, clot
activators and/or anticoagulants.
IMMULITE Thyroglobulin has not been
tested with all possible variations of tube
types. Consult the section on Alternate
Sample Types for details on tubes that
have been tested.
Volume Required: 50 µL serum or
heparinized plasma. (Sample cup must
contain at least 100 µL more than the total
volume required.)
Storage: 3 days at 2–8°C or
2 months at –20°C.
Warnings and Precautions
For in vitro diagnostic use.
CAUTION! POTENTIAL
BIOHAZARD
Contains human source
material. Each donation of
human blood or blood
component was tested by
FDA-approved methods for the
presence of antibodies to human
immunodeficiency virus type 1
(HIV-1) and type 2 (HIV-2) as
well as for hepatitis B surface
antigen (HBsAg) and antibody to
hepatitis C virus (HCV). The test
results were negative (not
repeatedly reactive). No test
offers complete assurance that
these or other infectious agents
are absent; this material should
be handled using good
laboratory practices and
universal precautions.
IMMULITE/IMMULITE 1000 Thyroglobulin (PILKTY-24, 2015-04-30)
CAUTION: This device contains material
of animal origin and should be handled as
a potential carrier and transmitter of
disease.
H302 + H312,
H412
P280, P273,
P301 + P312,
P302 + P312,
P501
Reagents: Store at 2–8°C. Dispose of in
accordance with applicable laws.
Follow universal precautions, and handle
all components as if capable of
transmitting infectious agents. Source
materials derived from human blood were
tested and found nonreactive for syphilis;
for antibodies to HIV 1 and 2; for
hepatitis B surface antigen; and for
antibodies to hepatitis C.
Sodium azide, at concentrations less than
0.1 g/dL, has been added as a
preservative. On disposal, flush with large
volumes of water to prevent the buildup of
potentially explosive metal azides in lead
and copper plumbing.
Chemiluminescent Substrate: Avoid
contamination and exposure to direct
sunlight. (See insert.)
Water: Use distilled or deionized water.
Materials Supplied
Components are a matched set. The
barcode labels are needed for the assay.
Thyroglobulin Test Units (LTY1)
Each barcode-labeled unit contains one
18-20
anti-ligand-coated bead. Stable at 2–8°C
until expiration date.
LKTY1: 100 units
Harmful if
Warning!
swallowed. Harmful in
contact with skin. Harmful to
aquatic life with long lasting
effects.
Wear protective
gloves/protective
clothing/eye protection/face
protection. Avoid release to
the environment. IF
SWALLOWED: Call a
POISON CENTER or
doctor/physician if you feel
unwell. IF ON SKIN: Call a
POISON CENTER or
doctor/physician if you feel
unwell. Dispose of contents
and container in accordance
with all local, regional, and
national regulations.
sodium azide;
:
Contains
Thyroglobulin Adjustors
3